In the future and based on previous findings showing that inhibition of SETD7 in other types of cancer improves response to chemotherapy [10,68,69,70,71,72], it would be interesting to explore if this subgroup of patients could benefit from targeting SETD7 with inhibitors to improve chemotherapy response. Here, SETD7 is linked to cancer.